Vanguard Group’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31B | Sell |
36,377,678
-299,770
| -0.8% | -$10.8M | 0.02% | 580 |
|
|
2025
Q1 | $1.14B | Sell |
36,677,448
-676,561
| -2% | -$21.1M | 0.02% | 604 |
|
|
2024
Q4 | $953M | Sell |
37,354,009
-231,114
| -0.6% | -$5.9M | 0.02% | 677 |
|
|
2024
Q3 | $1.06B | Sell |
37,585,123
-437,258
| -1% | -$12.4M | 0.02% | 645 |
|
|
2024
Q2 | $1B | Buy |
38,022,381
+322,699
| +0.9% | +$8.51M | 0.02% | 638 |
|
|
2024
Q1 | $1.14B | Sell |
37,699,682
-297,840
| -0.8% | -$9.05M | 0.02% | 603 |
|
|
2023
Q4 | $1.07B | Sell |
37,997,522
-1,439,832
| -4% | -$40.4M | 0.02% | 605 |
|
|
2023
Q3 | $1.07B | Buy |
39,437,354
+589,558
| +2% | +$16M | 0.03% | 576 |
|
|
2023
Q2 | $1.19B | Buy |
38,847,796
+917,777
| +2% | +$28.2M | 0.03% | 549 |
|
|
2023
Q1 | $1.37B | Buy |
37,930,019
+2,302,228
| +6% | +$82.9M | 0.03% | 497 |
|
|
2022
Q4 | $1.41B | Buy |
35,627,791
+675,981
| +2% | +$26.7M | 0.04% | 474 |
|
|
2022
Q3 | $1.4B | Buy |
34,951,810
+2,098,034
| +6% | +$84.3M | 0.04% | 449 |
|
|
2022
Q2 | $1.38B | Buy |
32,853,776
+993,155
| +3% | +$41.8M | 0.04% | 479 |
|
|
2022
Q1 | $1.24B | Buy |
31,860,621
+2,224,056
| +8% | +$86.6M | 0.03% | 561 |
|
|
2021
Q4 | $1.18B | Sell |
29,636,565
-391,497
| -1% | -$15.6M | 0.03% | 601 |
|
|
2021
Q3 | $1.09B | Buy |
30,028,062
+5,685,862
| +23% | +$205M | 0.03% | 608 |
|
|
2021
Q2 | $998M | Buy |
24,342,200
+1,829,607
| +8% | +$75M | 0.02% | 655 |
|
|
2021
Q1 | $982M | Buy |
22,512,593
+20,673,627
| +1,124% | +$902M | 0.03% | 635 |
|
|
2020
Q4 | $92M | Buy |
1,838,966
+426,080
| +30% | +$21.3M | ﹤0.01% | 1866 |
|
|
2020
Q3 | $59.4M | Buy |
1,412,886
+29,526
| +2% | +$1.24M | ﹤0.01% | 1919 |
|
|
2020
Q2 | $67.2M | Buy |
+1,383,360
| New | +$67.2M | ﹤0.01% | 1856 |
|